AmerisourceBergen Corporation (Holding Co) (ABC) witnessed a selling pressure and the shares last traded with a loss of -0.63 points or -0.72% at $86.65. Investors jumped in to buy the shares on weakness. The net money flow till latest update was calculated at $9.62 million with an inflow of $30.17 million in upticks and an outflow of $20.56 million in downticks. Using the data, the up/down ratio is found to be 1.47. The share price has recorded 5.12% on a weekly basis.A block trade of $7.34 million in uptick and $0 million in downtick was also observed, resulting in an up/down ratio of 0. The net money flow of the block trade stood at a $7.34, signaling heavy buying.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.
Shares of AmerisourceBergen Corporation rose by 3.24% in the last five trading days and 13.33% for the last 4 weeks. AmerisourceBergen Corporation is up 26.6% in the last 3-month period. Year-to-Date the stock performance stands at 13.33%. AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) rose 1.52% or 1.33 points on Wednesday and made its way into the gainers of the day. After trading began at $87.71 the stock was seen hitting $88.7 as a peak level and $86.09 as the lowest level. The stock ended up at $88.61. The daily volume was measured at 3,361,963 shares. The 52-week high of the share price is $92.48 and the 52-week low is $68.38. The company has a market cap of $19,228 million.
Company has reported several Insider transactions to the SEC, on Jan 4, 2017, Steven H Collis (Chairman, President & CEO) sold 15,000 shares at 80.39 per share price.On Sep 22, 2016, Henry Wadsworth Iii Mcgee (director) sold 3,351 shares at 82.10 per share price.On Sep 8, 2016, Kathy H. Gaddes (Executive Vice President) sold 681 shares at 88.15 per share price.
AmerisourceBergen Corp. Last issued its quarterly earnings results on Jan 31, 2017. The company reported $1.36 EPS for the quarter, beating the analyst consensus estimate by $ 0.13. Analyst had a consensus of $1.23. The company had revenue of $38169.30 million for the quarter, compared to analysts expectations of $39009.35 million. The companys revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.27 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.AmerisourceBergen Corp. was Upgraded by Leerink Partners to Outperform on Jan 17, 2017. AmerisourceBergen Corp. was Upgraded by BofA/Merrill to Buy on Jan 12, 2017. AmerisourceBergen Corp. was Downgraded by Mizuho on Jan 3, 2017 to Neutral, Price Target of the shares are set at $83.AmerisourceBergen Corp. was Upgraded by Morgan Stanley to Overweight on Nov 10, 2016. AmerisourceBergen Corp. was Upgraded by Mizuho on Nov 9, 2016 to Buy, Price Target of the shares are set at $83.
AmerisourceBergen Corporation provides pharmaceutical services. It distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers. The Company also provides pharmacy services to certain specialty drug patients. AmerisourceBergen Corporation is based in Chesterbrook, Pennsylvania.